Streetbeat News

Earnings

PRTH

Priority Technology Holdings' shares surged following the announcement of their Q4 financial results, which exceeded expectations. Additionally, the company provided FY24 revenue guidance that surpassed analyst estimates, indicating a positive outlook for future growth.

Portfolio Pulse from Benzinga Newsdesk

March 12, 2024 | 12:09 pm

RGLS

Regulus Therapeutics Inc (NASDAQ:RGLS) reported positive topline results from its Phase 1b study of RGLS8429 for Autosomal Dominant Polycystic Kidney Disease, showing clear evidence of a dose response and greater biological activity at higher doses. The drug was well tolerated with no safety concerns. Additionally, the company announced an oversubscribed $100 million equity private placement at $1.60 per share, with some investors opting for non-voting Class A-6 convertible preferred stock at $160.00 per share. Following the news, RGLS shares surged 52% to $2.11 in premarket trading.

Portfolio Pulse from Vandana Singh

March 12, 2024 | 12:08 pm

HRT

HireRight Holdings (NYSE:HRT) reported Q4 earnings of $0.23 per share, surpassing the $0.20 estimate, but its sales of $166.04M fell short of the $169.45M estimate. This reflects a decrease in both earnings and sales compared to the same period last year.

Portfolio Pulse from Happy Mohamed

March 12, 2024 | 12:08 pm

IKNA

Ikena Oncology (NASDAQ:IKNA) reported Q4 earnings with a per-share loss of $(0.41), slightly better than the expected $(0.43). However, their sales of $658K significantly missed the $3.14M estimate, marking a substantial decrease from the previous year's $5.45M.

Portfolio Pulse from Happy Mohamed

March 12, 2024 | 12:06 pm

ENFN

Enfusion (NYSE:ENFN) reported Q4 2023 adjusted EPS of $0.04, missing the consensus estimate of $0.05 by 20%. However, their sales of $46.486M exceeded the estimate of $45.275M by 2.67%, marking a 14.73% increase from the previous year.

Portfolio Pulse from Benzinga Newsdesk

March 12, 2024 | 12:05 pm

CRBP

Corbus Pharmaceuticals (CRBP) reported Q4 EPS of $(1.81), surpassing the $(2.36) estimate, marking a 23.31% beat and a 30.65% improvement year-over-year. The company's cash and investments total $127M, expected to sustain operations through Q1 2027.

Portfolio Pulse from Benzinga Newsdesk

March 12, 2024 | 12:05 pm

PLBY

PLBY Group, Inc. (NASDAQ:PLBY) announced it will restate its Q2 and Q3 2023 financials due to accounting errors related to an impaired Chinese license contract and commission expense adjustments. The restatements are expected to decrease net loss, increase Adjusted EBITDA, decrease total liabilities, with no impact on revenue, cash flows, liquidity, or future operations. The company will report its Q4 and full year 2023 financial results on March 27, 2024.

Portfolio Pulse from Benzinga Newsdesk

March 12, 2024 | 12:04 pm

RERE

ATRenew reported a year-over-year increase in Q4 financial results and issued positive Q1 revenue guidance, alongside announcing a $20 million share repurchase program. This has led to an increase in its share price.

Portfolio Pulse from Benzinga Newsdesk

March 12, 2024 | 12:03 pm

CMT

Core Molding Technologies (AMEX:CMT) reported Q4 adjusted EPS of $0.25, surpassing the $0.06 estimate, with sales of $73.78M exceeding the $70.75M forecast. However, this represents a decrease from the previous year's earnings and sales.

Portfolio Pulse from Benzinga Newsdesk

March 12, 2024 | 12:03 pm

POLA

Polar Power has announced new bookings worth $5.1 million in the first quarter of 2024, indicating a positive start to the year for the company.

Portfolio Pulse from Benzinga Newsdesk

March 12, 2024 | 12:03 pm